 |
 |

Modern Parathyroid Surgery
A Cost-benefit Analysis of Localizing Strategies
Bridget N. Fahy, MD;
Richard J. Bold, MD;
Laurel Beckett, PhD;
Philip D. Schneider, MD, PhD
Arch Surg. 2002;137:917-923.
Hypothesis Preoperative and intraoperative localizing techniques are more cost-effective than a nondirected bilateral neck exploration in the initial treatment of primary hyperparathyroidism (HPT).
Design A clinical outcome model was developed to simulate the surgical management of primary HPT. Clinical scenarios modeled included a nondirected bilateral neck exploration and surgery using the following localizing strategies: preoperative technetium Tc 99m sestamibi scanning, intraoperative "quick" intact parathyroid hormone assay, or intraoperative radioguidance. Average total charges based on intent to treat were estimated from our practice and from the literature.
Main Outcome Measures Average total charges per patient (for the primary operation and for reexploration for persistent HPT, if needed), incidence of surgical failure (ie, persistent HPT), and risk of recurrent laryngeal nerve injury (cumulative risk of the primary procedure and a subsequent operation for persistent HPT).
Results The use of any localizing strategy reduced total charges, risk of persistent HPT, and cumulative risk of recurrent laryngeal nerve injury compared with a nondirected bilateral neck exploration. The greatest cost savings and the lowest risk of recurrent laryngeal nerve injury were achieved when technetium Tc 99m sestamibi scanning was combined with intraoperative radioguidance. The lowest rate of persistent HPT was found when technetium Tc 99m sestamibi scanning was combined with an intraoperative parathyroid hormone assay.
Conclusions Limited parathyroid surgery using any localizing strategy is cost-effective, safe, and efficacious in the management of primary HPT. The cost benefit was primarily achieved by reduced operative charges and immediate hospital discharge rather than a lower need for reexploration for persistent HPT.
From the Division of Surgical Oncology, Departments of Surgery (Drs Fahy, Bold, and Schneider) and Epidemiology & Preventive Medicine (Dr Beckett), University of California, Davis, Sacramento.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Surgery
Arch Surg. 2002;137(8):881.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis
Sejean et al.
Eur J Endocrinol 2005;153:915-927.
ABSTRACT
| FULL TEXT
Clinicopathologic and Radiopharmacokinetic Factors Affecting Gamma Probe-Guided Parathyroidectomy
Ugur et al.
Arch Surg 2004;139:1175-1179.
ABSTRACT
| FULL TEXT
Rapid Intraoperative Immunoassay of Parathyroid Hormone and Other Hormones: A New Paradigm for Point-of-Care Testing
Sokoll et al.
Clin. Chem. 2004;50:1126-1135.
ABSTRACT
| FULL TEXT
Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy: A Lesson From Reoperative Parathyroidectomy
Axelrod et al.
Arch Surg 2003;138:1214-1218.
ABSTRACT
| FULL TEXT
Preoperative Localization and Radioguided Parathyroid Surgery
Mariani et al.
JNM 2003;44:1443-1458.
ABSTRACT
| FULL TEXT
|